We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Siemens Healthineers Showcases Role of Digitalization at AACC 2018

By LabMedica International staff writers
Posted on 31 Jul 2018
At the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, Siemens Healthineers (Erlangen, Germany) showcased an array of digital offerings that turn data into actionable information to address a variety of clinical and operational challenges facing laboratories.

Siemens Healthineers provided a preview of the soon-to-be-released Atellica Data Manager that delivers clinical details lab managers need to make informed decisions. More...
Atellica Data Manager operationalizes data from patient samples and QC results to standardize testing, optimize QC performance, and maximize the potential of autoverification while reducing operator interventions, unwarranted variations and errors. Open and scalable, Atellica Data Manager is built on the powerful CentraLink solution currently in use by 1,500+ laboratories in more than 50 countries to help optimize clinical operations, increase testing volumes and improve turnaround times.

At AACC 2018, Siemens Healthineers displayed Atellica Inventory Manager, which provides automated, real-time control over reagents and consumables across multiple lab locations to reduce inventory costs, save time, and improve efficiencies. Pre-labeled radio frequency identification (RFID) tags simplify inventory check-in, checkout, and consumption tracking, and, when enabled, consumables can be ordered automatically through cloud-enabled software.

Also on display at the event was Atellica Process Manager, which in addition to offering laboratories centralized control and visibility, now provides advanced analytics and business intelligence capabilities, enabling labs to gain real-time insight into hidden inefficiencies in their workflow. Out-of-the box and interactive reports enable lab managers to assess key metrics such as turnaround times, testing volumes, problem samples, and automation utilization.

Additionally, the company displayed POCcelerator Data Management System which is designed to address daily point-of-care challenges such as quality control, compliance and operator certification, and offers point-of-care coordinators vendor-neutral, open connectivity to more than 170 devices, giving coordinators visibility into results, quality controls, operators, reagents, and device data. The information is presented in a clear and structured format. Proactive error logs and a traffic-light system indicate potential problems that can be acknowledged with a single click.

Siemens Healthineers demonstrated its investment in transforming healthcare through digital innovations with its Digital Ecosystem. The open and secured cloud environment combines data from lab and imaging devices, which can be leveraged by applications from Siemens Healthineers and other partner companies to provide solutions to the lab. The company also showcased its first lab partner XIFIN and demonstrated how its Revenue Cycle Management solution helps to optimize the laboratory’s financial performance, by identifying potential outreach and outpatient testing reimbursement gaps.

Complementing the company’s digital offerings, Siemens Healthineers featured its Laboratory As A Business (LAAB) Consulting Service designed to address clinical, operational and financial challenges of laboratories, and help position the lab as a decision maker and a powerful contributor to the objectives of value-based care in health systems. LAAB recommends or structures sustainable solutions that help achieve strategic business objectives by leveraging the capabilities of the lab and informatics offerings, expertise, and competencies from Siemens Healthineers.


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: EvoLiver is the first test to receive FDA Breakthrough Device Designation in five years in the liver cancer surveillance space (Photo courtesy of Mursla Bio)

Patient-Friendly Blood Test to Transform Liver Cancer Surveillance

Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, is the fastest-growing cause of cancer-related deaths. Although clinical guidelines recommend routine surveillance for high-risk... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.